Brady Corp: Form 10-Q for the period ended Jan 31, 2014
Filed with the SEC on Mar 5, 2014 and accepted by EDGAR at Mar 5, 2014, 21:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-11-01 to 2014-01-31 | $291.2m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months2013-08-01 to 2014-01-31 | $598.7m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months2013-11-01 to 2014-01-31 | $148.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2013-08-01 to 2014-01-31 | $298.3m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-11-01 to 2014-01-31 | $142.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2013-08-01 to 2014-01-31 | $300.4m | us-gaap:GrossProfit |
| Research and development | 3 months2013-11-01 to 2014-01-31 | $8.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2013-08-01 to 2014-01-31 | $17.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2013-11-01 to 2014-01-31 | $111.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2013-08-01 to 2014-01-31 | $224.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-11-01 to 2014-01-31 | $18.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-08-01 to 2014-01-31 | $48.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-11-01 to 2014-01-31 | −$3.7m | us-gaap:InterestExpense |
| Interest expense | 6 months2013-08-01 to 2014-01-31 | −$7.4m | us-gaap:InterestExpense |
| Income tax | 3 months2013-11-01 to 2014-01-31 | $4.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2013-08-01 to 2014-01-31 | $13.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-11-01 to 2014-01-31 | $16.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2013-08-01 to 2014-01-31 | $40.4m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2013-11-01 to 2014-01-31 | 52,494,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2013-08-01 to 2014-01-31 | 52,457,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2013-08-01 to 2014-01-31 | $41.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2013-08-01 to 2014-01-31 | −$17.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2013-08-01 to 2014-01-31 | −$20.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2013-08-01 to 2014-01-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-01-31 | $79.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-01-31 | $519.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-01-31 | $1.44bn | us-gaap:Assets |
| Current liabilities | At period end2014-01-31 | $289.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-01-31 | $574.6m | us-gaap:Liabilities |
| Long-term debt | At period end2014-01-31 | $203.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-01-31 | $61.3m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2014-01-31 | $863.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000746598-14-000040. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.